UK Parliamentary Committee Warns of Dangerous Dependence on Palantir, Urges NHS to Exit Contract
On June 2, 2026, a bipartisan 11-member UK committee warned Palantir reliance is an “unacceptable point of weakness” that could increase vendor leverage and lead to costlier, lower-quality services. It urges the NHS to trigger a contract clause next February to exit, citing 2020 COVID use, $750M in NHS/MoD deals, and Peter Thiel’s 2023 “Stockholm syndrome” comments.